{"entity":{"type":"insider","cik":"0001640880","url":"/insider/0001640880","json_url":"/insider/0001640880.json","name":"TVM Life Science Ventures VII L.P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":3,"first":"2015-05-12","last":"2018-08-22","span_basis":"filed_date"},"name_variants":[{"name":"TVM Life Science Ventures VII L.P.","source":"filing","n_filings":3,"first_seen":"2015-05-12","last_seen":"2018-08-22"}],"transactions":[{"id":6181374,"accession":"0001012975-18-001040","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-18-001040","line_url":"/filing/0001012975-18-001040#line-1","is_derivative":false,"issuer_cik":"0001069308","issuer_name":"Acer Therapeutics Inc.","issuer_ticker":"ACER","issuer_name_source":null,"issuer_url":"/issuer/0001069308","owner_cik":null,"owner_name":"Birner Hubert; Beeby Reshentha; TVM Life Science Ventures VII L.P.; Fischer Stefan; Leatt Gary; SCHUHSLER HELMUT; Marengere Luc","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275000.0,"shares_display":"275,000","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":4950000.0,"total_display":"4,950,000.00","shares_owned_after":1697709.0,"shares_owned_after_display":"1,697,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-01","filed_date":"2018-08-22","scope":"insider"},{"id":5982427,"accession":"0001012975-18-000059","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001012975-18-000059","line_url":"/filing/0001012975-18-000059#line-3","is_derivative":false,"issuer_cik":"0001069308","issuer_name":"Acer Therapeutics Inc.","issuer_ticker":"ACER","issuer_name_source":null,"issuer_url":"/issuer/0001069308","owner_cik":null,"owner_name":"SCHUHSLER HELMUT; Wanless Mark; TVM Life Science Ventures VI GmbH & Co KG; Birner Hubert; Leatt Gary; TVM Life Science Ventures VII L.P.; Fischer Stefan; TVM Life Science Ventures VI LP; Marengere Luc","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","shares_owned_after":1422709.0,"shares_owned_after_display":"1,422,709","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2018-01-12","scope":"insider"},{"id":5982423,"accession":"0001012975-18-000059","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001012975-18-000059","line_url":"/filing/0001012975-18-000059#line-2","is_derivative":false,"issuer_cik":"0001069308","issuer_name":"Acer Therapeutics Inc.","issuer_ticker":"ACER","issuer_name_source":null,"issuer_url":"/issuer/0001069308","owner_cik":null,"owner_name":"SCHUHSLER HELMUT; Wanless Mark; TVM Life Science Ventures VI GmbH & Co KG; Birner Hubert; Leatt Gary; TVM Life Science Ventures VII L.P.; Fischer Stefan; TVM Life Science Ventures VI LP; Marengere Luc","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":62062.0,"shares_display":"62,062","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":744744.0,"total_display":"744,744.00","shares_owned_after":725844.0,"shares_owned_after_display":"725,844","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2018-01-12","scope":"insider"},{"id":5982421,"accession":"0001012975-18-000059","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001012975-18-000059","line_url":"/filing/0001012975-18-000059#line-1","is_derivative":false,"issuer_cik":"0001069308","issuer_name":"Acer Therapeutics Inc.","issuer_ticker":"ACER","issuer_name_source":null,"issuer_url":"/issuer/0001069308","owner_cik":null,"owner_name":"SCHUHSLER HELMUT; Wanless Mark; TVM Life Science Ventures VI GmbH & Co KG; Birner Hubert; Leatt Gary; TVM Life Science Ventures VII L.P.; Fischer Stefan; TVM Life Science Ventures VI LP; Marengere Luc","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":21271.0,"shares_display":"21,271","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":255252.0,"total_display":"255,252.00","shares_owned_after":248756.0,"shares_owned_after_display":"248,756","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-12","filed_date":"2018-01-12","scope":"insider"},{"id":8653732,"accession":"0000911916-15-000186","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000911916-15-000186","line_url":"/filing/0000911916-15-000186#line-2","is_derivative":false,"issuer_cik":"0001348649","issuer_name":"CoLucid Pharmaceuticals, Inc.","issuer_ticker":"CLCD","issuer_name_source":null,"issuer_url":"/issuer/0001348649","owner_cik":null,"owner_name":"TVM Life Science Ventures VII L.P.; Marengere Luc","owner_url":null,"role":"Director, Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":5000000.0,"total_display":"5,000,000.00","shares_owned_after":1495386.0,"shares_owned_after_display":"1,495,386","ownership_form":"I","is_10b5_1":null,"transaction_date":"2015-05-11","filed_date":"2015-05-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001069308","name":"Acer Therapeutics Inc.","url":"/issuer/0001069308","role":"Director, Ten percent owner","n_filings":2,"first_seen":"2018-01-12","last_seen":"2018-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001348649","name":"CoLucid Pharmaceuticals, Inc.","url":"/issuer/0001348649","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-12","last_seen":"2015-05-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001640880","retrieved_at":"2026-08-21T10:08:48+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}